Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6124513 | Osteoarthritis and Cartilage | 2016 | 34 Pages |
Abstract
In vitro engineered neo-cartilage tissue from primary chondrocytes, hPACs, exhibits a DNA methylation landscape that is almost identical (99% similarity) to autologous cartilage, in contrast to neo-cartilage engineered from bone marrow-derived mesenchymal stem cells (MSCs). Although hBMSCs are widely used for cartilage engineering purposes the effects of these vast differences on cartilage regeneration and long term consequences of implantation, are not known. The use of hBMSCs or hPACs for future cartilage tissue regeneration purposes should therefore be investigated in more depth in future endeavors to better understand the consequences of the differential methylome on neo-cartilage.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
N. Bomer, W. den Hollander, H. Suchiman, E. Houtman, R.C. Slieker, B.T. Heijmans, P.E. Slagboom, R.G.H.H. Nelissen, Y.F.M. Ramos, I. Meulenbelt,